Go Pro
→ Bezos… DOOMED (From Paradigm Press) (Ad)tc pixel Free LRMR Stock Alerts

Larimar Therapeutics (LRMR) Short Interest Ratio & Short Volume

Larimar Therapeutics logo
$4.01 -0.04 (-0.99%)
As of 08/28/2026 04:00 PM Eastern
Compare

Larimar Therapeutics Short Interest Overview

As of August 14, 2026, Larimar Therapeutics (LRMR) had a short interest of 13.44 million shares sold short, representing 13.48% of the public float. This marks a 10.28% increase in short interest since the prior report. The short interest ratio (days to cover) is 11.2, meaning it would take 11.2 days of the average trading volume of 1.07 million shares to cover all short positions.

Current Short Interest
13,443,456 shares
Previous Short Interest
12,190,367 shares
Change Vs. Previous Month
10.28%
Dollar Volume Sold Short
$58.61 million
Short Interest Ratio
11.2 Days to Cover
Last Record Date
August 14, 2026
Outstanding Shares
103,883,000 shares
Short Percent of Float
13.48%
Today's Trading Volume
641,495 shares
Average Trading Volume
1,068,580 shares
Today's Volume Vs. Average
60%
Short Selling Larimar Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Larimar Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LRMR Short Interest Over Time

LRMR Days to Cover Over Time

LRMR Percentage of Float Shorted Over Time

Larimar Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/14/202613,443,456 shares $58.61 million +10.3%13.5%11.23 $4.36
7/31/202612,190,367 shares $46.57 million +7.8%12.2%9.38 $3.82
7/15/202611,303,953 shares $43.07 million -7.3%11.4%4.89 $3.81
6/30/202612,193,251 shares $37.19 million +15.7%12.3%3.18 $3.05
6/15/202610,535,603 shares $37.82 million +30.9%10.6%5.06 $3.59
5/29/20268,046,494 shares $28.00 million -8.0%8.1%5.28 $3.48
5/15/20268,744,601 shares $31.31 million +5.2%8.8%4.32 $3.58
4/30/20268,309,598 shares $33.74 million +13.3%8.4%7.01 $4.06
4/15/20267,332,588 shares $35.42 million -4.0%7.4%4.97 $4.83
3/31/20267,639,333 shares $34.38 million +5.3%7.7%3.89 $4.50
3/13/20267,255,138 shares $33.30 million -5.7%7.3%2.69 $4.59
2/27/20267,692,689 shares $40.85 million -14.3%7.8%0.58 $5.31
2/13/20268,977,079 shares $28.28 million +2.4%9.0%10.63 $3.15
1/30/20268,765,467 shares $31.03 million +2.1%11.1%6.26 $3.54
1/15/20268,588,537 shares $28.00 million +4.2%10.9%7.61 $3.26
12/31/20258,240,719 shares $31.40 million +4.0%10.4%6.98 $3.81
12/15/20257,922,334 shares $31.06 million -19.2%10.0%5.83 $3.92
11/28/20259,804,662 shares $34.61 million -2.7%12.4%6.57 $3.53
11/14/202510,075,712 shares $34.06 million +10.7%12.7%5.85 $3.38
10/31/20259,103,944 shares $35.41 million +3.3%11.5%6.02 $3.89
10/15/20258,820,000 shares $37.40 million -1.3%11.2%3.3 $4.24
9/30/20258,940,000 shares $28.88 million +16.9%N/A3.6 $3.23
9/15/20257,650,000 shares $30.29 million +19.5%N/A5 $3.96
8/31/20256,400,000 shares $23.17 million +8.7%8.1%4.5 $3.62
8/15/20255,890,000 shares $23.62 million -7.5%N/A4.3 $4.01
7/31/20256,370,000 shares $22.04 million +3.6%8.1%4.8 $3.46
7/15/20256,150,000 shares $19.43 million -1.8%N/A4.8 $3.16
6/30/20256,260,000 shares $18.09 million -3.5%10.2%5 $2.89
6/15/20256,490,000 shares $18.69 million +1.9%10.6%5 $2.88
5/31/20256,370,000 shares $14.65 million -35.2%10.3%5.4 $2.30
5/15/20259,830,000 shares $18.38 million +64.7%16.0%9.3 $1.87
4/30/20255,970,000 shares $15.82 million +6.0%N/A6.2 $2.65
4/15/20255,630,000 shares $10.58 million +16.8%9.1%7 $1.88
3/31/20254,820,000 shares $10.36 million -5.1%7.8%6.7 $2.15
3/15/20255,080,000 shares $13.16 million -0.2%8.3%7.5 $2.59
2/28/20255,090,000 shares $15.42 million -5.4%8.3%7 $3.03
2/15/20255,380,000 shares $17.97 million +6.1%8.7%7.2 $3.34
1/31/20255,070,000 shares $19.47 million -3.2%N/A6.2 $3.84
1/15/20255,240,000 shares $17.82 million +3.4%N/A6.5 $3.40
12/31/20245,070,000 shares $19.62 million +13.4%N/A6.2 $3.87
Look at this $5 stock’s address (Ad)

A small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, right alongside SpaceX and Blue Origin. It holds a special agreement to use a multi-billion dollar federal launch facility for just $500, and its customer list already includes the Pentagon, Lockheed Martin, and GE Aerospace. Most Wall Street analysts have not caught on yet, but a major milestone could change that soon.tc pixel

Click here to see the company behind the gates
12/15/20244,470,000 shares $27.58 million +15.2%N/A5.2 $6.17
11/30/20243,880,000 shares $24.56 million +17.2%N/A5.3 $6.33
11/15/20243,310,000 shares $22.14 million +21.7%N/A4.6 $6.69
10/31/20242,720,000 shares $22.37 million -26.7%N/A4.2 $8.23
10/15/20243,710,000 shares $27.53 million +3.9%N/A6.6 $7.42
9/30/20243,570,000 shares $23.38 million +7.2%N/A6.4 $6.55
9/15/20243,330,000 shares $23.98 million -4.0%N/A5.8 $7.20
8/31/20243,470,000 shares $27.45 million -4.4%N/A6.9 $7.91
8/15/20243,630,000 shares $28.28 million +4.3%N/A7.1 $7.79
7/31/20243,480,000 shares $29.20 million -4.1%N/A5.9 $8.39
7/15/20243,630,000 shares $38.77 million +26.0%N/A6.4 $10.68
6/30/20242,880,000 shares $20.88 million -11.9%N/A5.3 $7.25
6/15/20243,270,000 shares $30.71 million +1.6%N/A6.9 $9.39
5/31/20243,220,000 shares $25.76 million -17.7%N/A6.2 $8.00
5/15/20243,910,000 shares $30.77 million +0.3%N/A8.2 $7.87
4/30/20243,900,000 shares $26.87 million +7.4%N/A6.1 $6.89
4/15/20243,630,000 shares $26.50 million +13.8%N/A5.8 $7.30
3/31/20243,190,000 shares $24.21 million +95.7%N/A5.5 $7.59
3/15/20241,630,000 shares $14.18 million +221.6%N/A2.9 $8.70
2/29/2024506,800 shares $5.83 million -18.0%N/A1.1 $11.50
2/15/2024618,200 shares $8.21 million +82.0%3.5%1.5 $13.28
1/31/2024339,700 shares $1.97 million -4.9%N/A2.2 $5.79
1/15/2024357,100 shares $1.65 million -8.4%N/A2.8 $4.61
12/31/2023390,000 shares $1.77 million -4.0%N/A3 $4.55
12/15/2023406,100 shares $1.71 million -16.5%N/A4.1 $4.22
11/30/2023486,400 shares $1.67 million -7.8%N/A4.6 $3.43
11/15/2023527,400 shares $1.55 million -8.6%N/A4.8 $2.93
10/31/2023576,900 shares $1.69 million +0.2%N/A4.9 $2.93
10/15/2023575,600 shares $1.69 million -11.3%N/A2.7 $2.93
9/30/2023648,700 shares $2.56 million +7.9%N/A3.2 $3.95
9/15/2023601,100 shares $2.55 million -5.1%N/A2.9 $4.24
8/31/2023633,200 shares $2.36 million +9.9%N/A2.3 $3.72
8/15/2023576,200 shares $2.41 million -12.9%N/A2 $4.18
7/31/2023661,800 shares $2.83 million +3.8%N/A1.8 $4.28
7/15/2023637,500 shares $2.05 million +7.3%N/A2.3 $3.21
6/30/2023594,100 shares $1.86 million +296.3%N/A2.1 $3.13
6/15/2023149,900 shares $509.66 thousand -23.9%N/A0.5 $3.40
5/31/2023197,000 shares $726.93 thousand -12.0%N/A0.8 $3.69
5/15/2023223,800 shares $803.44 thousand -14.3%N/A0.8 $3.59
4/30/2023261,000 shares $1.23 million -14.1%N/A1.2 $4.73
4/15/2023303,700 shares $1.38 million -1.2%N/A1.4 $4.53
3/31/2023307,500 shares $1.39 million -12.4%N/A1.5 $4.53
3/15/2023350,900 shares $2.03 million +3.0%N/A2 $5.79
2/28/2023340,600 shares $2.06 million +43.3%N/A1.9 $6.06
2/15/2023237,700 shares $1.41 million -6.2%N/A1.6 $5.93
1/31/2023253,300 shares $1.25 million -0.2%N/A2.2 $4.94
1/15/2023253,900 shares $1.18 million -1.1%N/A2.4 $4.65
12/30/2022256,800 shares $1.06 million -25.4%N/A2.4 $4.13
12/15/2022344,300 shares $1.57 million -9.7%N/A3 $4.56
11/30/2022381,300 shares $1.21 million +2.3%N/A2.2 $3.17
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
11/15/2022372,800 shares $1.13 million +12.5%N/A2.1 $3.03
10/31/2022331,500 shares $1.09 million +4.5%N/A1 $3.30
10/15/2022317,300 shares $970.94 thousand -2.9%N/A1 $3.06
9/30/2022326,700 shares $1.05 million +17.8%N/A1 $3.20
9/15/2022277,300 shares $934.50 thousand +2.0%1.6%0.9 $3.37
8/31/2022271,900 shares $739.57 thousand -21.9%1.6%1.2 $2.72
8/15/2022347,900 shares $866.27 thousand +93.0%2.0%1.7 $2.49
7/31/2022180,300 shares $322.74 thousand -8.9%1.1%5 $1.79
7/15/2022197,900 shares $385.91 thousand +4.0%1.2%5.1 $1.95
6/30/2022190,300 shares $372.99 thousand -4.4%1.1%5.5 $1.96
6/15/2022199,100 shares $457.93 thousand +0.6%1.2%5.8 $2.30
5/31/2022197,900 shares $510.58 thousand -33.8%1.2%4.3 $2.58
5/15/2022298,700 shares $761.69 thousand -49.0%1.8%4.9 $2.55
4/30/2022585,600 shares $2.17 million -6.9%3.5%2.7 $3.71
4/15/2022628,700 shares $2.22 million -4.1%3.8%3 $3.53
3/31/2022655,300 shares $2.65 million +2.2%3.9%3.1 $4.05
3/15/2022641,100 shares $2.69 million -7.5%3.9%3 $4.20
2/28/2022692,800 shares $3.02 million +66.9%4.2%3.2 $4.36
2/15/2022415,100 shares $1.66 million -0.4%2.5%1.9 $4.01
1/31/2022416,600 shares $4.04 million -20.0%2.5%8.8 $9.70
1/15/2022520,500 shares $4.76 million +16.2%3.1%11.7 $9.15
12/31/2021447,800 shares $4.83 million -9.9%2.7%9.5 $10.79
12/15/2021496,800 shares $4.81 million +1.3%3.0%11.2 $9.68
11/30/2021490,300 shares $4.51 million -4.7%3.0%9.4 $9.19
11/15/2021514,600 shares $5.65 million -2.7%3.1%11.6 $10.98
10/29/2021528,700 shares $6.32 million +3.1%3.3%8.6 $11.95
10/15/2021512,600 shares $6.21 million +3.0%3.2%7.6 $12.12
9/30/2021497,800 shares $5.74 million +10.6%3.1%7 $11.53
9/15/2021450,100 shares $5.60 million -4.9%2.8%3.5 $12.44
8/31/2021473,100 shares $6.81 million -2.6%2.9%3.6 $14.39

LRMR Short Interest - Frequently Asked Questions

Short interest is the volume of Larimar Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 14th, traders have sold 13,443,456 shares of LRMR short. 13.48% of Larimar Therapeutics' shares are currently sold short. Learn More on Larimar Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LRMR shares currently have a short interest ratio of 11.2. Learn More on Larimar Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.48% of Larimar Therapeutics' floating shares are currently sold short.

Larimar Therapeutics saw a increase in short interest in August. As of August 14th, there was short interest totaling 13,443,456 shares, an increase of 10.3% from the previous total of 12,190,367 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

13.48% of Larimar Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Larimar Therapeutics: AnaptysBio, Inc. (26.22%), Vir Biotechnology, Inc. (11.93%), Absci Corporation (24.37%), Maze Therapeutics, Inc. (11.38%), Forte Biosciences, Inc. (8.04%), Ascentage Pharma Group International - Unsponsored ADR (0.02%), Bicara Therapeutics Inc. (18.34%), Tyra Biosciences, Inc. (18.56%), First Tracks Biotherapeutics (10.89%), Inhibrx Biosciences, Inc. (26.73%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.57 billion), Invesco QQQ ($46.97 billion), iShares Russell 2000 ETF ($24.02 billion), Nebius Group N.V. ($15.37 billion), Sandisk Corporation ($12.60 billion), SPDR S&P Biotech ETF ($12.14 billion), Western Digital Corporation ($10.32 billion), iShares 20+ Year Treasury Bond ETF ($8.38 billion), VanEck Semiconductor ETF ($7.62 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.07 billion). View all of the most shorted stocks.

Short selling LRMR is an investing strategy that aims to generate trading profit from Larimar Therapeutics as its price is falling. LRMR shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Larimar Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LRMR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LRMR, twice per month. The most recent reporting period available is August, 14 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like LRMR:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:LRMR is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/25/2026. FINRA publishes updated short interest twice a month.
From Our Partners
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel
Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...
Porter & Company | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
SPDR Gold just lost $14 billion.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel
Buy These Stocks Before August 31st
Keith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwi...
TradeSmith | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Now that SpaceX is public, buy this ticker (no, not SpaceX or Tesla)
The SpaceX IPO wasn't the big trade - according to Larry Benedict, founder of The Opportunistic Trader, it was...
Brownstone Research | Sponsoredtc pixel